Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane

Abstract

Adrenocortical carcinoma (ACC) is an aggressive tumor with very poor prognosis. Novel medical treatment opportunities are required. We investigated the effects of interferon-b (IFN-b), alone or in combination with mitotane, on cell growth and cortisol secretion in primary cultures of 13 human ACCs, three adrenal hyperplasias, three adrenal adenomas, and in two ACC cell lines. Moreover, the interrelationship between the effects of IGF2 and IFN-b was evaluated. Mitotane inhibited cell total DNA content/well (representing cell number) in 7/11 (IC 50 : 38G9.2 mM) and cortisol secretion in 5/5 ACC cultures (IC 50 : 4.5G 0.1 mM). IFN-b reduced cell number in 10/11 (IC 50 : 83G18 IU/ml) and cortisol secretion in 5/5 ACC cultures (IC 50 : 7.3G1.5 IU/ml). The effect of IFN-b on cell number included the induction of apoptosis. IFN-b strongly inhibited mRNA expression of STAR, CYP11A1, CYP17A1, and CYP11B1. Mitotane and IFN-b induced an additive inhibitory effect on cell number and cortisol secretion. IGF2 (10 nM) inhibited apoptosis and increased cell number and cortisol secretion. These effects were counteracted by IFN-b treatment. Finally, IFN-b inhibited IGF2 secretion and mRNA expression. In conclusion, IFN-b is a potent inhibitor of ACC cell growth in human primary ACC cultures, partially mediated by an inhibition of the effects of IGF2, as well as its production. The increased sensitivity of ACC cells to mitotane induced by treatment with IFN-b may open the opportunity for combined treatment regimens with lower mitotane doses. The inhibition of the expression of steroidogenic enzymes by IFN-b is a novel mechanism that may explain its inhibitory effect on cortisol production. Key Words" adrenocortical carcinoma " type 1 interferons " interferon receptor " mitotane " insulin-like growth factor 2

Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells

“…In the current study, all the concentrations of mitotane used (from 10 -7 to 10 -5 M) were lower than the concentrations (4.3-6.3 9 10 -5 M) corresponding to the mitotane plasma level at the therapeutic range [14]. The addition of sirolimus to these low concentrations of mitotane showed higher antiproliferative effects than mitotane alone suggesting that combined treatment might have additive effects to the antineoplastic action of mitotane, permitting to reduce the dose required to obtain desired clinical effects.…”

Modulation of IGF2 Expression in the Murine Thymus and Thymic Epithelial Cells Following Coxsackievirus-B4 Infection

“…Whether TECs can be infected with CV-B4 in vivo remains to be determined, nevertheless, a downregulation of IGF2 expression in TECs of mice infected with the virus has been observed, which raises the hypothesis of indirect mechanisms involved in this effect. It was reported that both IFN-α and -β are inhibitors of IGF2 expression [60][61][62]. Besides, it was shown that inactivated CV-B virions can upregulate IFN production in immune cells, revealing that active intracellular viral replication is not required for IFN induction [63][64][65].…”

Cushing’s syndrome: an update on current pharmacotherapy and future directions

“…IFN-b demonstrated in vitro inhibition of steroidogenic enzymes and showed increased sensitivity of ACC cells to mitotane during combination therapy [139]. This is a promising finding as it comes to possible combined treatment regimens with lower doses of mitotane and IFN-b.…”